Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma

QR Code

Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma

Systemic therapy (ST) and transarterial radioembolization (TARE) are widely used treatments for advanced-stage hepatocellular carcinoma (HCC). This study quantified the significant variability in treatment costs for unresectable HCC from payer and provider perspectives. An Excel-based price analysis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abimbola O. Williams, Nicholas Anderson, Young-Gwan Gwon, Wendy Wifler
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Journal of Market Access & Health Policy
Subjects:	liver cancer hepatocellular carcinoma transarterial radioembolization systemic therapy treatment cost variability price analysis
Online Access:	https://www.mdpi.com/2001-6689/13/2/25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Evaluation of Intraarterial Therapy Methods for Hepatocellular Cancer
by: A. P. Petrosyan, et al.
Published: (2025-06-01)

Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
by: Natalie J. Rothenberger, et al.
Published: (2022-07-01)

Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection
by: Dongho Hyun
Published: (2025-07-01)

Complications of Radioembolization: Prevention and Management
by: Gyoung Min Kim
Published: (2025-07-01)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
by: Chengxiang Guo, et al.
Published: (2025-02-01)

Radioembolization: Technical Tips and Follow-Up Imaging
by: Hyo-Cheol Kim
Published: (2025-07-01)

Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation
by: Sofia Lopiano, et al.
Published: (2025-05-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

An Unusual Complication of Transarterial Radioembolization: Hepatic Artery Pseudoaneurysm and its Treatment with Ultrasound-guided Thrombin Injection
by: Muhammet Arslan, et al.
Published: (2023-07-01)

Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
by: Yu J, et al.
Published: (2025-07-01)

Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
by: Wenjie Li, et al.
Published: (2025-07-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

Liver Radioembolization: a New Chapter in Russian Oncology
by: A. D. Kaprin, et al.
Published: (2019-12-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma
by: Qingqing Pang, et al.
Published: (2025-07-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study
by: Liu J, et al.
Published: (2025-07-01)

Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma
by: Xia Y, et al.
Published: (2025-07-01)

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study
by: Lu C, et al.
Published: (2025-07-01)

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Yongfa Lei, et al.
Published: (2025-07-01)

DCP as a biomarker for TACE efficacy in hepatocellular carcinoma
by: Hui Xie, et al.
Published: (2025-07-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Evaluating the prognostic impact of inflammatory markers on treatment outcomes in patients with intrahepatic cholangiocarcinoma undergoing radioembolization
by: Sinan Sozutok, et al.
Published: (2025-07-01)

Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
by: Lu J, et al.
Published: (2025-05-01)

A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
by: Dai Y, et al.
Published: (2025-07-01)

Optimal sequencing of locoregional and systemic therapies for intermediate and advanced hepatocellular carcinoma: a network meta-analysis
by: Wei Lu, et al.
Published: (2025-06-01)

Pressure Gradient-Driven Embolization b-TACE for HCC: Technical and Diagnostic Step-by-Step Procedural Guide and Literature Review
by: Bianca Rocco, et al.
Published: (2025-07-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Zelong Liu, et al.
Published: (2025-09-01)

Development and Validation of a Radiomics Nomogram Based on Magnetic Resonance Imaging and Clinicoradiological Factors to Predict HCC TACE Refractoriness
by: Dong Y, et al.
Published: (2025-07-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Enhancing Transradial Transarterial Microembolization Efficiency and Patient Satisfaction with Oral Benzodiazepine Premedication
by: Hsuan-Yin Lin, et al.
Published: (2025-06-01)

CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
by: A. I. Gritsaenko, et al.
Published: (2017-01-01)

Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer
by: Yuefeng Hu, et al.
Published: (2025-12-01)

Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study
by: Bo Sun, et al.
Published: (2025-07-01)

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01)

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy
by: Ryosuke Tsunemitsu, et al.
Published: (2023-06-01)

Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma
by: Zhuoran Wang, et al.
Published: (2025-06-01)

Determinant of Property Price Through the Monetary Variables: An ARDL Approach
by: Mahrus Lutfi Adi Kurniawan, et al.
Published: (2023-04-01)